Nadi Tarangini, an indigenously developed pulse diagnostic tool, has become India’s first ayurvedic medical device to receive ...

India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...

Drugmaker Wockhardt on Thursday announced Central Drugs Standard Control Organization (CDSCO) approval for use of ... plans to launch Miqnaf in the Indian market in coming few months, Wockhardt ...

Shares of Wockhardt are higher by 5% on January 3 after Indian drug regulator ... in an exchange filing. Central Drugs Standard Control Organization (CDSCO) approved antibiotic Nafithromycin ...

The CDSCO, which is the apex body responsible for approval of new drugs and clinical trials, has issued an alert regarding this. According to latest data, they found 41 batches of drugs ...

Pune: Nadi Tarangini, the country's first ayurvedic diagnostic tool to receive approval from Central Drugs Standard Control Organization (CDSCO), is e.

CDSCO brings clinical trial site addition and change of PI applications to online mode: Gireesh Babu, New Delhi Thursday, January 2, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...

Despite the glorious performance of the pharmaceutical sector, India faced a huge setback because of the recent incident when ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

getting regulatory approval from the Central Drugs Standard Control Organization. Wockhardt expects to launch this product in Indian, in about two-three months, as local clearances are to be taken ...

The Central Drug Standards Control Organisation (CDSCO) found 41 batches of various drugs to be of sub-standard quality in ...